As a continuation of our ongoing studies aimed to depict the effects and mechanism of action of naturally occurring oxyprenylated phenylpropanoids and polyketides, in this paper we describe the synthesis and in vitro anti-proliferative effects of selected compounds belonging to the above cited classes of secondary metabolites on six cancer cell lines using the MTT colorimetric assay. Our study revealed that among the natural products tested, only oxyprenylated chalcones exhibited an appreciable effect (mean IC 50 = 32 -64 M), while substituted alcohols, phenylpropenes, naphthoquinones, and aminoacid derivatives were by far less active or inactive.
Prenylation is the chemical or enzymatic addition of a terpenyl moiety to an accepting molecule (for example, another terpenoid, an aromatic compound, a protein). This biochemical reaction occurs in nature in plant families like Rutaceae, Compositae, Apiaceae, Guttiferae, Leguminosae, and others, comprising several edible fruits and vegetables [1, 2] . Thus oxyprenylated natural products represent compounds of mixed origin for which the final step of the biosynthetic process is the prenylation of an alkaloid or a phenylpropanoid / polyketide core. Considering the length of the carbon chain, three types of prenyloxy skeletons can be classified: C5 (isopentenyl), C10 (geranyl) and C15 (farnesyl). To date about 350 oxyprenylated derivatives have been isolated and/or synthesized and were shown to possess a wide range of valuable and promising pharmacological activities [1, 2] .
Every year, approximately seven million people die from cancer, which makes this disease responsible for at least 12% of deaths worldwide [3] . A number of important new commercialized anticancer drugs have been obtained from natural sources [4] , including vinblastine, vincristine, vinorelbine, etoposide, teniposide, taxol, taxotere, topotecan and irinotecan from plants [5] . In fact, as emphasized by Tan et al. [6] , natural products have been the most significant sources of drugs, accounting for approximately 74% of anticancer drugs. Thus, as claimed both by Coseri [3] and Gordaliza [4] , natural products represent the most valuable potential source of novel anticancer agents. In this context we have already recently reported that some oxyprenylated secondary metabolites exert an effective in vitro growth inhibitory effect against a wide panel of human cancer cell lines [7] . Thus the search of novel oxyprenylated phenylpropanoids and polyketides as alternative anticancer agents is a field of current and growing interest. In this work, we characterized the in vitro growth inhibitory activity of 15 selected oxyprenylated phenylpropanoids, polyketides, napthtoquinones, and aminoacid derivatives. The in vitro IC 50 growth inhibitory concentrations of each phytochemical were determined in six human cancer cell lines using the MTT colorimetric assay. The compounds under investigation in the present paper are illustrated below. Batalin [19] , and finally chalcones (15) from Helichrysum [20] , Pleiotaxis [21] , and Metalasia spp. [22] .
The synthesis of compounds 1-8 and 12 was accomplished following the already reported methodology [23] . Compounds 9-11 were obtained from commercially available eugenol, isoeugenol, and 4-allyl-2,6-dimethoxyphenol in 99%, 97%, and 61% yields, respectively using the described Williamson reaction of isopentenylation of phenols [23] . As outlined in Scheme 1, xinjiachalcone A (13) was synthesized by a two-step process starting from commercially available 4-hydroxy-2methoxybenzaldehyde that was first alkylated by the usual methodology, as depicted above, with 3,3-dimethylallyl bromide and K 2 CO 3 in acetone at 80°C for 2 h; the corresponding adduct was then subjected to an aldol condensation by reaction with 4-hydroxyacetophenone in a 60% hydroalcoholic solution of KOH at reflux for 3 h to provide, after acid-base work-up, the desired product 13 in 53% overall yield. (2E)-1-{2,6-Dihydroxy-4-[(3methylbut-2-enyl)oxy]phenyl}-3-(4-hydroxyphenyl)prop-2-en-1-one (14) and (15) were both synthesized starting from commercially available 2,4,6-trihydroxyacetophenone that was first selectively alkylated in position 4 with 3,3dimethylallylbromide in the presence of the sterically hindered base 1,5-diazabicylo[5.4.0]-undecene (commonly known as DBU) in acetone at room temperature for 3 h, and then the obtained adduct was made to react with either 4-hydroxybenzaldehyde or benzaldehyde under the same aldol condensation experimental conditions as described above providing 14 and 15 in 25% and 30% yields, respectively after crystallization with n-hexane (Scheme 2). All the synthesized oxyprenylated products were then assessed for their in vitro anti-proliferative effects on a panel of six cancer cell lines exhibiting different levels of resistance to pro-apoptotic stimuli using the MTT colorimetric assay. Results are reported in Table 1 . The lack of a reference drug is justified by the fact that practically all the cancer cell lines, except PC3 cells, have been selected to be resistant to the most common therapeutically used chemotherapeutic agents.
From data reported in Table1 it is evident that, among the compounds tested, only chalcones and the benzyl alcohol 6 displayed an appreciable level of activity, while the tyrosine derivative 1, benzaldehydes, phenylethanols or phenylpropanols, and all phenylpropenes displayed either a weak or no activity (IC 50 > 100 µM). Among the chalcones, xinjiachalcone A (13) was found to be the most effective agent, revealing more uniform growth inhibitory values on all six cancer cell lines ranging from a minimum of 27 µM against the LoVo line to a maximum of 38 µM against the PC3 one. The two other chalcones, 14 and 15, were by far less effective, especially against U373, Hs683, and SKMEL-28 lines. However, the recorded pattern of results is in line with the current knowledge about natural and semi-synthetic chalcones as anti-proliferative agents [24] . 3,5-Dimethoxy-4isopentenyloxybenzyl alcohol (6) was finally the only one phytochemical, not belonging to the chalcone group, for which IC 50 values were < 100 µM for all six cancer cell lines, although recorded parameters revealed only a weak effect. In general, LoVo cells were seen to be the most sensitive lines among the ones under investigation. In fact 12 out of 15 compounds recorded an IC 50 value < 100 µM. These cells are widely used as a model of colorectal cancer, which in turn is known to be one of the main causes of death for cancer worldwide. Being oxyprenylated secondary metabolites well spread in several edible fruits and vegetables, such a higher sensitivity of adenocarcinoma cells might be of great interest in the near future for the development of cancer chemopreventive strategies as well as to properly address the synthesis of semisynthetic analogues of the title compounds with enhanced growth inhibitory activities. Such studies are now ongoing in our laboratories. 1-8 and 12 were synthesized following the already methodology [23] . 4-Isopentenyloxyeugenol (9), 4isopentenyloxyisoeugenol (10), and 2,6-dimethoxy-4isopentenyloxy-allylbenzene (11) were obtained starting from commercially available eugenol, isoeugenol, and 4-allyl-2,6dimethoxyphenol in 99%, 97%, and 61% yields, respectively using the described methodology of isopentenylation of phenols [23] . Analytical data for each adduct were in full agreement with those reported in the literature for the same compound [20] [21] [22] .
Anti-proliferative activity of oxyprenylated chalcones Natural Product Communications Vol. 8 (8) 2013 1091 Xinjiachalcone A (13): To a stirred solution of 4-hydroxy-2methoxybenzaldehyde (3.3 mmol) in acetone (15 mL) dry K 2 CO 3 (3.3 mmol) was added and the resulting suspension was kept at 80°C for 5 min. 3,3-Dimethylallyl bromide was then poured into the reaction mixture that was made to react at the same temperature for 1 h. The resulting solution was diluted with H 2 O (150 mL) and extracted with n-hexane (3 x 30 mL). The collected organic phases were dried over Na 2 SO 4 and evaporated to dryness under vacuum yielding a white solid structurally characterized as 4-isopentenyl-2methoxybenzaldehyde by NMR, IR, and GC-MS. This compound (1.0 mmol) and 4-hydroxyacetophenone (1.5 mmol) were dissolved in EtOH (6 mL) and to the resulting mixture a 60% solution of KOH in water (6 mL) was added and reacted at 100°C for 3 h. The resulting suspension was cooled and poured into water (300 mL) and extracted with n-hexane (3 x 20 mL). The aqueous solution was acidified with HCl 10% and extracted with CH 2 Cl 2 (2 x 50 mL). The collected organic phases were dried over Na 2 SO 4 and evaporated to dryness under vacuum and the desired product was obtained after crystallization with n-hexane. Analytical data were in full agreement with those reported in the literature for the same compound [19] .
Synthesis of chalcones 14 and 15. General procdure:
To a stirred solution of 2,4,6-trihydroxyacetophenone (10.7 mmol) in acetone (50 mL) DBU (10.7 mmol) was added and the resulting mixture made to react for 5 min. 3,3-Dimethylallyl bromide was then poured into the reaction medium, and the resulting solution was kept for 3 h at room temperature, then diluted with a 10% solution of HCl (300 mL), and finally extracted with n-hexane (3 x 50 mL). The collected organic phases were dried over Na 2 SO 4 and evaporated to dryness under vacuum yielding a white solid structurally characterized as 2,6-dihydroxy-4-isopentenyloxyacetophenone by NMR, IR, and GC-MS. The same procedure described previously for the synthesis The determination of the IC 50 growth inhibitory concentrations in vitro was carried out by means of the MTT colorimetric assay, as detailed previously [25] [26] [27] . Briefly, this test measures the number of metabolically active (thus living) cells that are able to transform the yellow substrate 3-(4,5-dimethylthazol-2-yl)-2,5diphenyltetrazolium bromide (MTT) into the blue formazan dye via a mitochondrial reduction involving succinate dehydrogenase. The amount of formazan obtained at the end of the experiment (measured by spectrophotometry) is directly proportional to the number of living cells. The determination of the optical density in the control compared with the treated cells therefore enables quantitative measurements of the effects of compounds on the growth of normal as well as cancer cells in vitro. Each experimental condition was assessed in 6 replicates.
